Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 2
1954 1
1955 1
1957 1
1958 2
1960 1
1966 1
2001 2
2002 1
2003 2
2004 3
2005 4
2006 4
2007 1
2008 3
2009 7
2010 7
2011 13
2012 14
2013 8
2014 4
2015 6
2016 11
2017 19
2018 30
2019 21
2020 27
2021 30
2022 53
2023 44
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

300 results

Results by year

Filters applied: . Clear all
Page 1
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Tu E, Vera-Badillo F, Williams SG, Yip S, Zhang AY, Zielinski RR, Sweeney CJ; ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Davis ID, et al. N Engl J Med. 2019 Jul 11;381(2):121-131. doi: 10.1056/NEJMoa1903835. Epub 2019 Jun 2. N Engl J Med. 2019. PMID: 31157964 Clinical Trial.
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
Sweeney CJ, Martin AJ, Stockler MR, Begbie S, Cheung L, Chi KN, Chowdhury S, Frydenberg M, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Vera-Badillo F, Williams SG, Winter D, Yip S, Zhang AY, Zielinski RR, Davis ID; ENZAMET trial investigators and Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Sweeney CJ, et al. Lancet Oncol. 2023 Apr;24(4):323-334. doi: 10.1016/S1470-2045(23)00063-3. Lancet Oncol. 2023. PMID: 36990608 Clinical Trial.
Editorial: Recent advances in hypospadiology.
Abbas T, Fernandez N, Harper L. Abbas T, et al. Front Pediatr. 2023 Nov 21;11:1226156. doi: 10.3389/fped.2023.1226156. eCollection 2023. Front Pediatr. 2023. PMID: 38078325 Free PMC article. No abstract available.
ZEB1 promotes non-homologous end joining double-strand break repair.
Genetta TL, Hurwitz JC, Clark EA, Herold BT, Khalil S, Abbas T, Larner JM. Genetta TL, et al. Among authors: abbas t. Nucleic Acids Res. 2023 Oct 13;51(18):9863-9879. doi: 10.1093/nar/gkad723. Nucleic Acids Res. 2023. PMID: 37665026 Free PMC article.
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study.
Chen EX, Jonker DJ, Loree JM, Kennecke HF, Berry SR, Couture F, Ahmad CE, Goffin JR, Kavan P, Harb M, Colwell B, Samimi S, Samson B, Abbas T, Aucoin N, Aubin F, Koski SL, Wei AC, Magoski NM, Tu D, O'Callaghan CJ. Chen EX, et al. Among authors: abbas t. JAMA Oncol. 2020 Jun 1;6(6):831-838. doi: 10.1001/jamaoncol.2020.0910. JAMA Oncol. 2020. PMID: 32379280 Free PMC article. Clinical Trial.
Systemic therapies in vitiligo: a review.
Fatima S, Abbas T, Refat MA, Harris JE, Lim HW, Hamzavi IH, Mohammad TF. Fatima S, et al. Among authors: abbas t. Int J Dermatol. 2023 Mar;62(3):279-289. doi: 10.1111/ijd.16114. Epub 2022 Feb 7. Int J Dermatol. 2023. PMID: 35133006 Review.
Craniopharyngioma: A lower-middle-income-country epidemiology.
Khalid MU, Shah MM, Bajwa MH, Mirza FA, Laghari AA, Raghib MF, Anis SB, Akhunzada NZ; Pakistan Brain Tumour Consortium; Siddiqi S, Enam SA; Pakistan Brain Tumour Consortium Group Names. Khalid MU, et al. J Pak Med Assoc. 2022 Nov;72(Suppl 4)(11):S61-S67. doi: 10.47391/JPMA.11-S4-AKUB10. J Pak Med Assoc. 2022. PMID: 36591630 Free article.
Schwannoma: A surgical epidemiology.
Khalid MU, Shah MM, Bajwa MH, Nathani KR, Laghari AA, Raghib MF, Anis SB, Akhunzada NZ; Pakistan Brain Tumour Consortium; Siddiqi S, Enam SA; Pakistan Brain Tumour Consortium Group Names. Khalid MU, et al. J Pak Med Assoc. 2022 Nov;72(Suppl 4)(11):S40-S45. doi: 10.47391/JPMA.11-S4-AKUB06. J Pak Med Assoc. 2022. PMID: 36591626 Free article.
Genomic instability in cancer.
Abbas T, Keaton MA, Dutta A. Abbas T, et al. Cold Spring Harb Perspect Biol. 2013 Mar 1;5(3):a012914. doi: 10.1101/cshperspect.a012914. Cold Spring Harb Perspect Biol. 2013. PMID: 23335075 Free PMC article. Review.
300 results